NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...

Produced by Biomass Magazine and BBI International, the event is the largest gathering of biomass industry stakeholders ...

The Texas A&M AgriLife Extension Service and Texas A&M Department of Horticultural Sciences will host a virtual Texas Fruit ...

CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic ...

ClinNEXUS management will be in attendance during "JPM Week" hosting investor meetings and sharing its new corporate presentation- LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, (or the ...

Join industry leaders, innovators, and researchers for the AATCC Coloration Conference, February 24–25, 2026, at the ...

Abstract: Network protocol reverse engineering is crucial for a wide range of security applications. Many existing techniques accomplish this task by analyzing network traces. However, these methods ...

To request an in-person meeting with Gain management on Wednesday during the week of the J.P. Morgan Healthcare Conference, either register at LifeSci Partners Corporate Access Event 2026 or contact ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

44 th Annual J.P. Morgan Healthcare Conference Format: Presentation and one-on-one investor meetings Date: January 15, 2026 Presentation Time 8:15 a.m. PST/11:15am EST Webcast Link: Click Here ...